Overview Fundamentals API Earnings EOD API Sample Code Pricing

Pharming Group NV (PHAR NASDAQ) stock market data APIs

$8.51 0(0%) as of July 19, 2024
Price chart is built with Anychart

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Pharming Group NV Financial Data Overview

8.51
8.51
-
8.51
8.51
6.97-16.71
583 M
67 344 K
258 M
-0.1851
0.799
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PHAR',
Type: 'Common Stock',
Name: 'Pharming Group NV',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00YN70VB3',
ISIN: NULL,
CUSIP: NULL,
CIK: '1828316',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-12-23',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Pharming Group NV Fundamental Data is available in our Financial Data APIs

  • Net Revenue 258 M
  • EBITDA -14 323 000
  • Earnings Per Share -0.16
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Pharming Group NV Earnings via APIs

  • Latest Release 2024-05-08
  • EPS/Forecast 0

Get Pharming Group NV End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com